Gilles Avenard
Europe, Ile-de-France, France, Paris
Description
Board member or advisor for several biotech companies ; co-founder and COO of BioAlliance Pharma SA – ONXEO (NYSE EURONEXT) until 2010. Gill...
Investor Profile
Gilles Avenard has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- France (100%)
Industry Focus
- Biopharma
- Biotechnology
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.